LRRK2 and Parkinson disease: As compared to healthy age-matched controls, R1441G-LRRK2 PD and G2019S-LRRK2 PD lymphocytes displayed a C/C splitting phenotype which was reverted by MLi2 in all cases (Fig. 6a–c).